Literature DB >> 3663330

cDNA cloning of human inter-alpha-trypsin inhibitor discloses three different proteins.

T Schreitmüller1, K Hochstrasser, P W Reisinger, E Wachter, W Gebhard.   

Abstract

Inter-alpha-trypsin inhibitor (ITI) is a serum protein of unknown function. Part of the molecule (formerly called HI30) is closely related to a tumor-derived protein acting as a growth factor for endothelial cells. We screened a human liver cDNA expression library with antibodies raised against human ITI and isolated several clones which could be divided into three groups according to their DNA sequences. The cDNA of the first group codes for a protein composed of alpha 1-microglobulin (alpha 1M) and urinary trypsin inhibitor (UTI) and is identical to that encoded by a clone originally found by screening a human liver cDNA library with oligonucleotides derived from amino-acid sequences of the two Kunitz-type domains of UTI. The proteins derived from the cDNA of the second and the third group of clones are distantly related to each other, but unrelated to the protein derived from group 1 clones. Partial amino-acid sequencing of ITI isolated from serum allowed the verification of large parts of the cDNA-derived amino-acid sequences. The results favour the view that ITI is not a single chain protein, but rather a very tight complex of several components or a mixture of such complexes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3663330     DOI: 10.1515/bchm3.1987.368.2.963

Source DB:  PubMed          Journal:  Biol Chem Hoppe Seyler        ISSN: 0177-3593


  9 in total

1.  A "new" genetic polymorphism of a human serum protein: inter-alpha-trypsin-inhibitor.

Authors:  U Vogt; H Cleve
Journal:  Hum Genet       Date:  1990-01       Impact factor: 4.132

2.  Genetic polymorphism of inter-alpha-trypsin-inhibitor (ITI): formal genetic and linkage analyses.

Authors:  C Luckenbach; J Kömpf; H Ritter
Journal:  Hum Genet       Date:  1991-05       Impact factor: 4.132

Review 3.  A physiological function of serum proteoglycan bikunin: the chondroitin sulfate moiety plays a central role.

Authors:  Lisheng Zhuo; Antonietta Salustri; Koji Kimata
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

4.  Genetic polymorphism of inter-alpha-trypsin inhibitor (ITI) in the Basque Country (northern Spain).

Authors:  O García; A Alonso; A Aguirre; C de la Rua; C Manzano
Journal:  Int J Legal Med       Date:  1993       Impact factor: 2.686

5.  Human inter-alpha-trypsin inhibitor. Synthesis and maturation in hepatoma HepG2 cells.

Authors:  J Bourguignon; R Sesboüé; M Diarra-Mehrpour; M Daveau; J P Martin
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

6.  Distribution and localization of inter-alpha-trypsin inhibitor and its active component acid-stable proteinase inhibitor: comparative immunohistochemical study.

Authors:  E Yoshida; H Sumi; H Tsushima; M Maruyama; H Mihara
Journal:  Inflammation       Date:  1991-02       Impact factor: 4.092

7.  Human inter-alpha-inhibitor family in inflammation: simultaneous synthesis of positive and negative acute-phase proteins.

Authors:  M Daveau; P Rouet; M Scotte; L Faye; M Hiron; J P Lebreton; J P Salier
Journal:  Biochem J       Date:  1993-06-01       Impact factor: 3.857

8.  Immunohistochemical demonstration of bikunin, a light chain of inter-alpha-trypsin inhibitor, in human brain tumors.

Authors:  E Yoshida; M Maruyama; M Sugiki; H Mihara
Journal:  Inflammation       Date:  1994-12       Impact factor: 4.092

9.  Factor IX Zutphen: a Cys18-->Arg mutation results in formation of a heterodimer with alpha 1-microglobulin and the inability to form a calcium-induced conformation.

Authors:  E G Wojcik; M van den Berg; I K van der Linden; S R Poort; R Cupers; R M Bertina
Journal:  Biochem J       Date:  1995-11-01       Impact factor: 3.857

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.